Inhibitors of myeloperoxidase such as 4-aminobenzoic acid hydrazide have been used instead in mouse models of SLE and in vasculitis complicated by glomerulonephritis: the main finding was that they limited the accumulation of neutrophils in the glomeruli and also reduced proteinuria. Here, MPO is linked to systemic lupus erythematosus.